Thromboelastographic modifications induced by intravenous and subcutaneous heparin administration.
Traverso
C I
CI
Department of Surgery and Related Specialties, University of Granada Hospital, Spain.
Caprini
J A
JA
Arcelus
J I
JI
Arcelus
I M
IM
D000328:Adult; D000368:Aged; D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects*; D004285:Dogs; D005337:Fibrin / Q000378:metabolism; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000379:methods*; D011183:Postoperative Complications / Q000097:blood; D012015:Reference Standards; D013916:Thrombelastography / Q000592:standards
D000925:Anticoagulants; D005337:Fibrin; D006493:Heparin